How Finta unlocked RxPost's $1.1 Million Round


"Finta changed my entire approach to fundraising to something that looked more like a sales pipeline. Once I started using it to track people and push them through a pipeline, I started seeing more success and quickly started closing investors." - Amantha Bagdon, RxPost founder and CEO
Inventory management is a big part of the job at independent pharmacies. They often form ad hoc networks to sell expensive medications to each other before they expire. But this system relies on phone calls, emails and often POs scrawled on pieces of paper.
Amantha Bagdon knew there had to be a better way. The former pharmacy tech – who came up with the idea while working at an independent pharmacy in Los Angeles - founded RxPost to solve the inventory management challenges that plague her customers.
Her customers are more efficient. They are able to liquidate unused inventory and boost revenue. And the automated system frees up pharmacists to take care of the people in their community.
Small wonder the company is red hot.
Growing RxPost
Since Amantha ran her business-to-business marketplace through Slauson & Co.’s Friends & Family accelerator in 2024, the company has taken off.
RxPost has seen revenue increase by 4,882% from around this time last year, coinciding with its expansion into the New York state market and rapid adoption by many new customers.
RxPost and its growing team are focused on leveraging the collective power of their customers, so that they can easily sell, track and record medications.
This is a best practice among corporate pharmacies, and by providing a software venue and proven process, the team hopes to improve the overall performance of community pharmacies in a deeply competitive market.
Pre-Seed round
Amantha, RxPost founder and CEO, decided in 2024 to open a pre-seed round so the business could grow along with its customer base.
RxPost ultimately raised more than $1 million from institutional investors and individual angels.
The round is paving the way for hiring experts in the pharmacy world who can perform high-level customer success among clients, along with investing in the company’s engineering team around founding engineer Brendon Hoffman.
Why the company used Finta
Amantha was introduced to Finta through Rohit Gupta, who leads venture capital firm Future Communities Capital, and which also invested in Finta.
She previously had been managing her raise in the ad hoc manner typical of early-stage companies, with phone calls, emails and the power of her own memory.
She immediately recognized the power behind Finta’s software, which creates a process reminiscent of a sales funnel, automated and personalized to closing capital.
Through Finta’s CRM, she began to populate that funnel with promising leads and then to track her process with more than 100 individual investors. She also leaned on the ability of Finta’s AI to enrich her research on investors and find warm introductions to them. Leveraging Finta Networks, Amantha had private access to shared connections via Future Communities Capital.
“Finta is helpful because it’s a process, not just a tool, so it changed my entire approach to fundraising to something that looked more like a sales pipeline,” Amantha said. “Once I started using it to track people and push them through a pipeline, I started seeing more success and quickly started closing investors.”
Takeaways
A fast-growing B2B marketplace that automates inventory management for community-based pharmacies, leveraging their collective power to save them time and money.
RxPost achieved rapid growth from 2024 until now, with sales skyrocketing about 4,882% percent compared to last year.
RxPost’s oversubscribed $1 million-plus pre-seed round was raised through Finta and will support investment across the business to support its growth.
RxPost founder and CEO Amantha Bagdon said the company will likely begin raising a true seed round sometime in the next 18 months. And when that happens, she plans to use Finta to manage her raise.